The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Maladaptive plasticity of serotonin axon terminals in levodopa‐induced dyskinesia
Abstract
Objective: Striatal serotonin projections have been implicated in levodopa‐induced dyskinesia by providing an unregulated source of dopamine release. We set out to determine whether these projections are affected by levodopa treatment in a way that would favor the occurrence of dyskinesia. Methods: As an index of terminal serotonin innervation density, we measured radioligand binding to the plasma membrane serotonin transporter (SERT) in levodopa‐treated dyskinetic and nondyskinetic subjects, using brain tissue from both rat and monkey models of Parkinson disease as well as parkinsonian patients. In addition, striatal tissue from dyskinetic rats was used for morphological and ultrastructural analyses of serotonin axon terminals, and for studies of stimulated [3 H]dopamine release. Results: Across all conditions examined, striatal levels of SERT radioligand binding were significantly elevated in dyskinetic subjects compared to nondyskinetic cases. In the rat striatum, dyskinesiogenic levodopa treatment had induced sprouting of serotonin axon varicosities having a relatively high synaptic incidence. This response was associated with increased depolarization‐induced [3 H]dopamine release and with a stronger release potentiation by brain‐derived neurotrophic factor. Interpretation: This study provides the first evidence that L‐dopa treatment induces sprouting of serotonin axon terminals, with an increased incidence of synaptic contacts, and a larger activity‐dependent potentiation of dopamine release in the dopamine‐denervated striatum. Treatment‐induced plasticity of the serotonin innervation may therefore represent a previously unappreciated cause of altered dopamine dynamics. These results are important for understanding the mechanisms by which L‐dopa pharmacotherapy predisposes to dyskinesia, and for defining biomarkers of motor complications in Parkinsons disease. Ann Neurol 2010
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders
Mattson, M. P., Maudsley, S., & Martin, B. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.08.001 · Cited by 942
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia
Picconi, B., Centonze, D., Håkansson, K., Bernardi, G., Greengard, P., Fisone, G., Cenci, M. A., & Calabresi, P. (2003) · Nature Neuroscience · doi:10.1038/nn1040 · Cited by 821
Self-citationDopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats
Carta, M., Carlsson, T., Kirik, D., & Bjorklund, A. (2007) · Brain · doi:10.1093/brain/awm082 · Cited by 636
BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization
Guillin, O., Diaz, J., Carroll, P., Griffon, N., Schwartz, J.-C., & Sokoloff, P. (2001) · Nature · doi:10.1038/35075076 · Cited by 574
New insights into brain BDNF function in normal aging and Alzheimer disease
Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.07.007 · Cited by 571
Levodopa motor complications in Parkinson's disease
Obeso, J. A., Olanow, C. W., & Nutt, J. G. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00031-8 · Cited by 478
de la Fuente-Fernandez, R. (2004) · Brain · doi:10.1093/brain/awh290 · Cited by 402
Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease
Kish, S. J., Tong, J., Hornykiewicz, O., Rajput, A., Chang, L.-J., Guttman, M., & Furukawa, Y. (2007) · Brain · doi:10.1093/brain/awm239 · Cited by 375
Andersson, M., Hilbertson, A., & Cenci, M. A. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0259 · Cited by 350
Self-citationMamounas, L. A., Altar, C. A., Blue, M. E., Kaplan, D. R., Tessarollo, L., & Lyons, W. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00771.2000 · Cited by 344
New insights into the role of brain-derived neurotrophic factor in synaptic plasticity
Waterhouse, E. G., & Xu, B. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.06.009 · Cited by 341
Voon, V., Fernagut, P.-O., Wickens, J., Baunez, C., Rodriguez, M., Pavon, N., Juncos, J. L., Obeso, J. A., & Bezard, E. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70287-x · Cited by 335
Self-citationTanaka, H., Kannari, K., Maeda, T., Tomiyama, M., Suda, T., & Matsunaga, M. (1999) · NeuroReport · doi:10.1097/00001756-199902250-00034 · Cited by 302
Westin, J. E., Vercammen, L., Strome, E. M., Konradi, C., & Cenci, M. A. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.11.032 · Cited by 277
Self-citationLindgren, H. S., Andersson, D. R., Lagerkvist, S., Nissbrandt, H., & Cenci, M. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06556.x · Cited by 263
Self-citationCombined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
Munoz, A., Li, Q., Gardoni, F., Marcello, E., Qin, C., Carlsson, T., Kirik, D., Di Luca, M., Bjorklund, A., Bezard, E., et al. (2008) · Brain · doi:10.1093/brain/awn235 · Cited by 241
Self-citationPost‐ versus presynaptic plasticity in L‐DOPA‐induced dyskinesia
Cenci, M. A., & Lundblad, M. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04124.x · Cited by 218
Self-citationAxonal sprouting following lesions of the rat substantia nigra
Finkelstein, D. I., Stanic*, D., Parish, C. L., Tomas, D., Dickson, K., & Horne, M. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00009-9 · Cited by 201
Clinical correlates of levodopa-induced dopamine release in Parkinson disease: A PET study
Pavese, N., Evans, A. H., Tai, Y. F., Hotton, G., Brooks, D. J., Lees, A. J., & Piccini, P. (2006) · Neurology · doi:10.1212/01.wnl.0000242888.30755.5d · Cited by 191
Self-citationCarlsson, T., Carta, M., Winkler, C., Björklund, A., & Kirik, D. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2079-07.2007 · Cited by 191
Navailles, S., Bioulac, B., Gross, C., & De Deurwaerdère, P. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.01.012 · Cited by 187
Role of striatal l ‐DOPA in the production of dyskinesia in 6‐hydroxydopamine lesioned rats
Carta, M., Lindgren, H. S., Lundblad, M., Stancampiano, R., Fadda, F., & Cenci, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03696.x · Cited by 157
Self-citationBDNF val66met influences time to onset of levodopa induced dyskinesia in Parkinson's disease
Foltynie, T., Cheeran, B., Williams‐Gray, C. H., Edwards, M. J., Schneider, S. A., Weinberger, D. R., Rothwell, J. C., Barker, R., & Bhatia, K. P. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.154294 · Cited by 150
Meissner, W. G., Ravenscroft, P., Reese, R., Harnack, D., Morgenstern, R., Kupsch, A. R., Klitgaard, H., Bioulac, B. H., Gross, C. E., Bézard, E., et al. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.009 · Cited by 150
Zhang, X., Andrén, P. E., Greengard, P., & Svenningsson, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711839105 · Cited by 125
Levodopa-induced dyskinesia: a pathological form of striatal synaptic plasticity?
Calabresi, P. A., Giacomini, P., Centonze, D., & Bernardi, G. (2000) · PubMed · Cited by 123
Raab, S., & Plate, K. H. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0228-3 · Cited by 120
Goggi, J., Pullar, I. A., Carney, S. L., & Bradford, H. F. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02505-2 · Cited by 117
New ideas on the origin of l-dopa-induced dyskinesias: age, genes and neural plasticity
Linazasoro, G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.06.007 · Cited by 108
Advances in understanding l-DOPA-induced dyskinesia
Cenci, M. A., & Lindgren, H. S. (2007) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2008.01.004 · Cited by 104
Self-citationLindgren, H. S., Ohlin, K. E., & Cenci, M. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.74 · Cited by 87
Self-citationAging of the serotonergic system in the rat forebrain: An immunocytochemical and neurochemical study
van Luijtelaar, M. G. P. A., Tonnaer, J. A. D. M., & Steinbusch, H. W. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90032-s · Cited by 87
Dupre, K. B., Jaunarajs, K. L. E., Barnum, C. J., & Bishop, C. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.031 · Cited by 85
Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications
Sossi, V., de la Fuente‐Fernández, R., Schulzer, M., Adams, J. R., & Stoessl, A. J. (2006) · Brain · doi:10.1093/brain/awl028 · Cited by 78
Hirsch, É. C. (2000) · PubMed · Cited by 51
Parent, M., Wallman, M., & Descarries, L. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07143.x · Cited by 33
Self-citationDori, I., Dinopoulos, A., & Parnavelas, J. G. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6937 · Cited by 32
Descarries, L., Soucy, J., Laeaille, F., et al. (1995) · Synapse · doi:10.1002/syn.890210206 · Cited by 29
Self-citationStructural Organization of Monoamine and Acetylcholine Neuron Systems in the Rat CNS
Descarries, L., & Mechawar, N. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_1 · Cited by 18
Self-citation
Cited by
Circuit Mechanisms of Parkinson’s Disease
McGregor, M. M., & Nelson, A. B. (2019) · Neuron · doi:10.1016/j.neuron.2019.03.004 · Cited by 624
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
Bastide, M. F., Meissner, W. G., Picconi, B., Fasano, S., Fernagut, P.-O., Feyder, M., Francardo, V., Alcacer, C., Ding, Y., Brambilla, R., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.002 · Cited by 475
The Pharmacology of l-DOPA-Induced Dyskinesia in Parkinson’s Disease
Huot, P., Johnston, T. H., Koprich, J. B., Fox, S. H., & Brotchie, J. M. (2013) · Pharmacological Reviews · doi:10.1124/pr.111.005678 · Cited by 324
Serotonin in Parkinson's disease
Politis, M., & Niccolini, F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.037 · Cited by 306
The serotonergic system in Parkinson's disease
Huot, P., Fox, S. H., & Brotchie, J. M. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.004 · Cited by 195
Metadata
- Authors
- Rylander, D., Parent, M., O'Sullivan, S. S., Dovero, S., Lees, A. J., Bezard, E., Descarries, L., & Cenci, M. A.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2010-09-29
- Volume
- 68
- Issue
- 5
- Pages
- 619-628
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2112559108
- Cited by
- 262
- References
- 39
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.